Is Iboga Legal in Gabon?
Iboga has never been prohibited in Gabon. But export has been suspended since 2019, and since May 2026 the whole chain needs ministerial authorisation.
Iboga is not a prohibited substance in Gabon, and Bwiti practice is conducted openly and lawfully. It does not follow that iboga is unrestricted there. An arrêté has suspended its export since February 2019, and a decree of 22 May 2026 requires authorisation across the whole chain, from access through research to sale. Gabon has not left iboga alone. It has claimed it.
This site carries legality pages for eighteen jurisdictions, including four American states. Until today it carried none for the country the plant comes from. That absence is not ours alone: English-language surveys of ibogaine law routinely run from Australia to the United States without stopping in Central Africa, and when they do stop there it is usually to say that iboga is legal and move on.
Legal, in Gabon, has a specific and consequential meaning that the one-word answer destroys.
What is lawful
Iboga is used in Gabon as a sacrament. Bwiti initiations happen, they are not clandestine, and the plant is not treated by the Gabonese state as a narcotic to be suppressed. We have found no Gabonese instrument placing iboga in a drug schedule, and the two texts that do exist in the gazette regulate it rather than prohibit it.
So the common claim is right in its core: a person in Gabon is not committing a drug offence by taking iboga. The Bwiti religion covers that practice on its own terms.
Everything else in the common claim is wrong.
The instrument that stops the plant leaving
An arrêté of 4 February 2019, published in the Journal Officiel, suspended the export of Tabernanthe iboga à titre conservatoire, in whole or in part, raw or derived. Exceptional authorisations remain possible after technical advice.
Three things follow, and none of them appears in the usual summary.
The suspension covers the plant and anything made from it, so an extract does not escape it by no longer looking like bark. It is a conservation measure rather than a drug-control measure, which is why it sits with a ministry of forests and environment rather than health. And it has now stood for over seven years, which means that the phrase “unregulated export”, still common in writing about iboga, has been wrong for most of the period it purports to describe.
The gap between “legal in Gabon” and “free in Gabon” is exactly the gap a traveller falls into. Someone who reads the first and concludes they may take material home has misread a conservation suspension as an absence of law.
The suspension attaches to the material crossing the border, not to the character or intentions of the person carrying it. Having taken part in a ceremony confers nothing here.
The instrument that claims the whole chain
On 22 May 2026, décret n° 0239/PR/MJSRCAVA entered the gazette. It regulates access, use, exploitation, research, processing and commercialisation of iboga.
Read the list again, because its breadth is the point. It is not an export rule and not a possession rule. It reaches the researcher, the processor and the seller alike. This is a state asserting control over a biological resource across its entire life, in the manner of a mineral or a fishery rather than a plant that happens to grow in the forest.
It is a framework rather than a prohibition. That distinction matters and it cuts both ways: nothing in it makes iboga illegal, and nothing in it leaves the chain open either.
The decree is three months old. It has barely entered the English-language conversation, which continues to describe a legal vacuum that the source country has been filling since 2019.
Why this is the page that governs the others
Every other legality page on this site describes what a destination country does about a molecule. This one describes what the origin country does about a plant, and the two kinds of rule answer to different logics.
A schedule asks whether a substance is dangerous. Gabon’s instruments ask who owns a species, who may work with it, and what leaves. That is the vocabulary of the Nagoya Protocol on access and benefit sharing, not the vocabulary of drug control, and it explains why a reader looking for Gabon in a table of drug schedules will not find it.
There is an irony in the supply chain that the origin story tends to obscure. Much of the ibogaine administered in clinics is not extracted from Gabonese iboga at all. It is made semi-synthetically from voacangine, drawn from the bark of a different and more abundant African tree, and the published chemistry describes that tree as the primary source of commercially available material.
Gabon is where the plant, the knowledge and the practice come from. It is not necessarily where the drug in the bottle comes from, and nobody has published what share it supplies. Where ibogaine actually comes from sets out what is and is not known.
What we could not establish
Iboga is very widely called Gabon’s national heritage plant, and a Council of Ministers declaration to that effect, dated July 2000, is reported in the Gabonese press. We have not located a primary instrument behind it. The claim may well be sound; we do not repeat it as law until we can read the text.
The short answer
Iboga is lawful to use in Gabon and it is not lawful to take out. Since May 2026 the state has claimed authority over access, research, processing and sale as well.
“One hundred per cent legal” survives only as far as the first border.
Iboga in Gabon covers the plant, the harvest and the ethics of who earns from it. Why ibogaine is illegal covers how the rest of the world arrived at a different set of answers.
Common questions
Sources
3 sources · How we source
- Arrêté n° 001/MFEPC/CAB-M du 04/02/2019 portant suspension à titre conservatoire de l'exportation de Tabernanthe iboga
- Décret n° 0239/PR/MJSRCAVA du 22 mai 2026 réglementant l'accès, l'usage, l'exploitation, la recherche, la transformation et la commercialisation de l'iboga
- Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization